[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"myofascial-pain-of-upper-trapezius-muscle\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:myofascial-pain-of-upper-trapezius-muscle":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,71],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100630645","comparison-of-the-effectiveness-of-exercise-dry-needling-and-interfascial-block-treatments-in-the-treatment-of-myofascial-pain-syndrome-100630645",false,"NCT07490366","Comparison of the Effectiveness of Exercise, Dry Needling and Interfascial Block Treatments in the Treatment of Myofascial Pain Syndrome","Inclusion Criteria:\n\n* Myofascial pain in the upper trapezius muscle that has lasted for at least 3 months\n* VAS score of 4 or higher for the current pain\n* Clinically diagnosed with myofascial pain in the trapezius muscle\n* Ages 18 to 55\n* Patients who can follow verbal instructions and have no cognitive deficits\n\nExclusion Criteria:\n\n* Having received interventional injections in the neck and shoulder area within the last 3 months\n* Having received physical therapy within the last 3 months\n* Having received regular nonsteroidal anti-inflammatory and myorelaxant treatment within the last month\n* History of surgery on the affected side (neck or shoulder)\n* Chronic inflammatory disease\n* Acute infection\n* History of malignancy\n* Coagulation disorders\n* Pregnancy\n* Liver and kidney pathologies\n* Drug allergy","ALL","18 Years","55 Years",{"count":19,"type":20},78,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study aimed to compare interfascial block therapy with commonly used exercise therapy and conventional invasive dry needling therapy, and to evaluate its effectiveness and superiority. Another objective of this study was to evaluate and compare the short-term and long-term effectiveness of interfascial block, dry needling, and exercise therapies on pain, disability, and quality of life in patients with myofascial pain syndrome. In this respect, our study is important in terms of its contribution to the literature.",[26],"Myofascial Pain of Upper Trapezius Muscle",[28,29,30,31],"myofascial pain","hydrodissection","dry needling","exercise","RECRUITING","2026-03-18",{"date":35,"type":36},"2026-03-24","ACTUAL",{"date":38,"type":36},"2025-08-01",{"date":40,"type":20},"2026-10-01",{"name":42,"class":43},"Eren Başıbüyük","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":21,"phases":55,"briefSummary":57,"conditions":58,"keywords":59,"overallStatus":61,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":44},"100628061","phase-4-comparison-of-the-effectiveness-of-dry-needling-versus-the-combination-of-dry-needling-and-local-anesthetic-injection-in-myofascial-pain-syndrome-of-the-upper-trapezius-muscle-a-sham-controlled-randomized-clinical-trial-100628061","NCT07456735","Comparison of the Effectiveness of Dry Needling Versus the Combination of Dry Needling and Local Anesthetic Injection in Myofascial Pain Syndrome of the Upper Trapezius Muscle: A Sham-Controlled, Randomized Clinical Trial","Comparison of the Effectivenes of Combined Dry Needling and Local Anesthetic Injection in Myofascial Pain Syndrome in Upper Trapezius Muscle","Inclusion Criteria:\n\n* Being between 18 and 65 years of age\n\n  * Having a diagnosis of myofascial pain syndrome with at least one active trigger point in the upper trapezius muscle according to the criteria of Travell and Simons\n  * Having signed the informed consent form regarding the study\n  * Having a history of muscle pain with VAS \\>3 persisting for at least four weeks in the same area (upper trapezius muscle)\n\nExclusion Criteria:\n\n* Having a diagnosis of cervical disc herniation, cervical radiculopathy, or myelopathy\n\n  * A history of central or peripheral nervous system disease (e.g., multiple sclerosis, stroke, peripheral neuropathy)\n  * Diagnosis of a major psychiatric disorder (major depression, anxiety disorder, bipolar disorder, schizophrenia) or receiving active psychiatric treatment\n  * Having bleeding diathesis, thrombocytopenia, or using anticoagulant\u002Fantiplatelet therapy for any reason (e.g., warfarin, clopidogrel)\n  * Presence of local infection at the injection site, dermatological lesions disrupting skin integrity, or signs of systemic infection\n  * Being pregnant or breastfeeding\n  * Having undergone injection, prolotherapy, or similar interventional treatment in the upper trapezius region within the last 6 months\n  * Having received dry needling treatment in any region previously\n  * A history of orthopedic or neurosurgical surgery involving the cervical spine, shoulder, or upper trapezius muscle region within the last year\n  * Having a diagnosis of uncontrolled diabetes mellitus or advanced-stage chronic disease (e.g., congestive heart failure, renal failure)\n  * Having a diagnosis of malignancy or systemic rheumatologic disease (e.g., rheumatoid arthritis, fibromyalgia syndrome, lupus)\n  * Having communication difficulties, cognitive impairment, or severe visual\u002Fhearing loss that could prevent participation in the study\n  * Having social\u002Flogistical barriers (e.g., transportation difficulties) that would prevent regular participation in the study process","65 Years",{"count":54,"type":20},90,[56],"PHASE4","This study was designed to compare the effectiveness of three different treatment protocols in patients diagnosed with myofascial pain syndrome of the upper trapezius muscle. A total of 90 volunteers aged between 18 and 65 years, with active trigger points identified in the upper trapezius muscle, will be included in the study. Participants will be randomly assigned to three groups:\n\n* Group 1: Dry needling and stretching exercises\n* Group 2: Dry needling following local anesthetic injection with 1% lidocaine and stretching exercises\n* Group 3 (Control): Sham dry needling following local anesthetic injection with 1% lidocaine and stretching exercises\n\nIn all groups, treatment sessions will be administered at weeks 0, 1, 2, and 3; and participants will undergo clinical assessments at baseline (pre-treatment), at the end of treatment, one month after treatment completion, and three months after treatment completion. The primary outcome will be pain severity, measured using the Numeric Pain Rating Scale (NRS); secondary outcomes will include functional status evaluated with the Neck Pain and Disability Scale (NPADS) and QuickDASH, and muscle tenderness assessed by pressure pain threshold (PPT) measurement. The findings are expected to contribute scientifically to clinical practice by identifying the most effective treatment combination for managing upper trapezius myofascial pain syndrome.",[26],[60],"myofascial pain syndrome,trigger points,dry needling","NOT_YET_RECRUITING","2026-03-02",{"date":64,"type":36},"2026-03-06",{"date":66,"type":20},"2026-03-01",{"date":68,"type":20},"2026-06-10",{"name":70,"class":43},"Emre Ata, Assoc Prof",{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":78,"enrollmentInfo":79,"targetDuration":4,"studyType":21,"phases":81,"briefSummary":82,"conditions":83,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":44},"100615595","percutaneous-electrolysis-of-the-upper-trapezius-in-chronic-neck-pain-100615595","NCT07294651","Percutaneous Electrolysis of the Upper Trapezius in Chronic Neck Pain","Effectiveness of Different Percutaneous Electrolysis Treatment Protocols Targeting the Upper Trapezius Muscle in Chronic Neck Pain: A Randomized Controlled Trial","Inclusion Criteria:\n\nPatients who agree to participate in the study, are between 18 and 70 years of age, have had symptoms for at least 3 months, and have chronic neck pain with active myofascial trigger points in the upper trapezius muscle will be included.\n\nExclusion Criteria:\n\nPatients with malignancy, active infection, a history of widespread inflammatory rheumatic disease or fibromyalgia, trauma, skin lesions, infection or open wounds at the myofascial trigger point region, coagulopathy, warfarin use, a history of spinal or shoulder disorders, previous neck or upper extremity surgery, acute illness, muscle diseases, epilepsy, use of sedative medications, needle phobia, previous dry needling treatment for myofascial pain, a cardiac pacemaker, metal implants in the treatment area, conditions that contraindicate physiotherapy such as pregnancy, or metal allergy will not be included in the study.","70 Years",{"count":80,"type":20},40,[23],"In the planned study, we aim to investigate the effectiveness of percutaneous electrolysis treatment applied to myofascial trigger points in the upper trapezius muscle in patients with chronic neck pain. Two different protocols, a low-intensity (0.5 mA × 90 s) and a high-intensity (3 mA × 3 s × 3 repetitions), will be compared in the study.\n\nPatients participating in the research will be randomized into 2 groups using a computer program. Stretching exercises targeting the upper trapezius muscle will be given to both groups as a home exercise program. In both groups, the percutaneous electrolysis treatment protocol will be performed on the active myofascial trigger points in the upper trapezius muscle on the 1st, 8th, and 14th days of treatment, using 0.3-millimeter acupuncture needles and an EPTE® percutaneous electrolysis device (Ionclinics \\& A. Deionic SL, Valencia, Spain). The low-intensity (0.5 milliampere × 90 s) treatment protocol will be applied to Group 1, and the high-intensity (3 milliampere × 3 s × 3 repetitions) treatment protocol will be applied to Group 2. In the study, two different protocols, low-intensity (0.5 mA × 90 s) and high-intensity (3 mA × 3 s × 3 repetitions), will be compared. In this way, it is aimed both to obtain information about optimal dosing and to contribute to the literature for a frequently involved muscle such as the upper trapezius.",[26],"2025-12-08",{"date":86,"type":36},"2025-12-19",{"date":88,"type":36},"2025-11-01",{"date":90,"type":20},"2026-04-10",{"name":92,"class":43},"Sivas State Hospital"]